Drug
Fasinumab
Fasinumab: highest development phase Phase 2/3, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fasinumab NCT02620020 | Phase 2/3 | Low Back Pain |
Latest
No recent events.
Follow Fasinumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.